Skip to main content

18 March 2021

OXGENE - TESSA Infographic

Download PDF – 1.5 MB

The challenge of scalable AAV manufacture for
gene therapies, and how to overcome it.

Gene therapies offer enormous promise for the treatment of genetic disease. There
are over 1,000 cell and gene therapy clinical trials underway worldwide, indicating
the great potential of this new class of medicines. However, large-scale
manufacture of the viral vectors required to deliver therapeutic genes into patients
still represents a stumbling block in the path to market for gene therapies...

Download our free infographic to find out more about the top solutions for large scale AAV production.

Download the resource to continue reading.